
GSK vs NBP
$GSK vs $NBP head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
GSK vs NBP: trend, levels and the market
One year to 2026-11-20, against the S&P 500 (+3.2%). Split-adjusted daily closes.
- ·Both are in downtrends, below their 50- and 200-day averages, so neither has turned up yet.
- ·Neither kept up with the market over the past year: GSK +1.6% and NBP -79.3%, against the S&P 500 at +3.2%.
Support and resistance are daily prices the stock has turned at three or more times, within 35% of the price. The loading zone is the nearby price where the heaviest volume traded. These describe where a stock has been, not where it will go. Not investment advice.
GSK vs NBP: the quick read
- ·GSK is the larger company by market cap ($95.73B vs $96M).
- ·GSK has been more active on our scanner (78 vs 58 alerts in 30 days).
- ·NBP has the smaller float (115.6M vs 2.00B), which tends to mean sharper, more volatile moves.
- ·Both are pharmaceutical preparations names, so this is a like-for-like comparison and sector news tends to move them together.
- ·They trade in different worlds by share price: NBP is a low-priced stock where a few cents is a real percentage move, while the other is priced for steadier increments.
- ·Both stay busy on our scanner, 78 and 58 unusual-volume alerts over 30 days, so neither is the quiet one here.
- ·They are not really peers by size: GSK is more than 997x the market cap of NBP, so the same dollar of news moves NBP far harder.
- ·Both sit in the bottom quarter of their 52-week range, so this is a comparison of two names well off their highs.
- ·GSK pays a dividend and NBP does not, which usually means one is being held for income and the other for the move.
- ·They are pulling apart today: GSK is outperforming the other by roughly 6.0 percentage points on the session.
Objective differences only. Not investment advice.
Watching GSK or NBP? Get each morning’s movers by email
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing GSK and NBP on TheDesperateTrader.
- Is GSK or NBP the better stock?
- "Better" depends on your goal, and these two are not alike. GSK is the larger company by market cap ($95.73B vs $96M). GSK has been more active on our scanner (78 vs 58 alerts in 30 days). NBP has the smaller float (115.6M vs 2.00B), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between GSK and NBP?
- The differences that matter: GSK is roughly 997x the size of the other by market cap ($95.73B vs $96M); they trade at very different share prices ($47.96 vs $0.83); GSK sits at 14% of its 52-week range against 2% for NBP; only GSK pays a dividend; our scanner flagged GSK 78 times in the last 30 days against 58 for NBP. Everything above is measured from the latest completed session and SEC filings.
- Which of GSK and NBP is more active right now?
- Right now GSK is at about 0.6x its normal volume and NBP is at about 1.9x, so NBP is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is GSK or NBP in the stronger trend?
- GSK is below its 50-day average of $49.31 and below its 200-day average of $52.25; NBP is below its 50-day average of $1.24 and below its 200-day average of $1.98. GSK leads 4 of the 5 measures on this page (1 year, vs S&P 500, 3 months, 1 month, trend). A trend is where a stock has been, not a forecast, and nothing here is investment advice.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading GSK or NBP? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysExplore the market
Free, live market tools. No account required to look.